Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
11
2023
 FDA Publishes Proposed Rule Permitting Salt Substitutes in Standardized Foods Keller and Heckman LLP
Apr
11
2023
 This Week in 340B: April 4 – 10, 2023 McDermott Will & Emery
Apr
11
2023
 Solicitor General Provides Views of the United States on Section VIII Carve-Outs, Induced Patent Infringement in GSK v. Teva Greenberg Traurig, LLP
Apr
11
2023
 Green Marketing Claims to Receive Increased Scrutiny Beveridge & Diamond PC
Apr
10
2023
 FDA To Require Demonstration of Cybersecurity Safeguards for Pre-Market Submissions of Certain Medical Devices Sheppard, Mullin, Richter & Hampton LLP
Apr
10
2023
 Khan's FTC Reportedly Reviving Price Discrimination Law to Investigate What Big Retailers Pay for Cola MoginRubin
Apr
10
2023
 Honey I Shrunk the Whisky? Class Action Alleges Fraud over Mini Bottle Labeling ArentFox Schiff LLP
Apr
10
2023
 Plaintiffs Argue There is No Evidence FDA Will Act Soon on “Natural” Definition Keller and Heckman LLP
Apr
10
2023
 What FQHCs Need to Know About Telehealth After the PHE Foley & Lardner LLP
Apr
8
2023
 Statement from Attorney General Merrick B. Garland The U.S. Department of Justice
Apr
7
2023
 Texas Lab Settles Unnecessary Drug Testing Allegations for $6 Million ArentFox Schiff LLP
Apr
7
2023
 Potential Nitrosamine Contamination Results in Another Voluntary Pharmaceutical Recall Nelson Mullins
Apr
7
2023
 When Keeping Medication Safe May Lead to Increased Liability McDermott Will & Emery
Apr
7
2023
 CMS Issues Medicare Drug Price Negotiation Initial Guidance, First Inflation Rebate List McDermott Will & Emery
Apr
7
2023
 CMS Updates Could Help Employers on Second Round of Drug Cost Reporting Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
6
2023
 No Smoking Gun Here: Soliciting Input Sufficient to Satisfy Commission’s Statutory Obligation McDermott Will & Emery
Apr
6
2023
 News Alert: Public Consultation on the EU’s Tobacco Products Legislation: Comment Period Open Until May 16, 2023 Keller and Heckman LLP
Apr
6
2023
 DOC’s Bureau of Economic Analysis Releases Report on Developing a National Measure of the Economic Contributors of the Bioeconomy Bergeson & Campbell, P.C.
Apr
6
2023
 FDA Announces First-Ever AI/ML Medical Device Draft Guidance Nelson Mullins
Apr
5
2023
 D’Addario v. Johnson & Johnson – New Jersey Federal Court Addresses Express Pre-Emption In Class III Medical Device Case Sills Cummis & Gross P.C.
Apr
5
2023
 “All Fruit” Jelly Label Continues to be Challenged in New York Federal Court Keller and Heckman LLP
Apr
5
2023
 DOD Publishes Biomanufacturing Strategy and RFI on Biomanufactured Products and Process Capabilities Bergeson & Campbell, P.C.
Apr
4
2023
 Is CMS Ignoring the Realities of Biopharmaceutical Costs? Epstein Becker & Green, P.C.
Apr
4
2023
 COVID-19 Related Medical Devices: FDA Finalizes Transition Plan Guidance Foley & Lardner LLP
Apr
4
2023
 Unpacking Averages: FDA FOIA Response Times by Topic of Request Epstein Becker & Green, P.C.
Apr
4
2023
 Lawsuit Forces Early Release of NTP’s Draft Report on Fluoride, and its Potential Association with Neurodevelopment and Cognition ArentFox Schiff LLP
Apr
4
2023
 White House Report Identifies Precision Medicine for Future R & D Investment Foley & Lardner LLP
Apr
4
2023
 FDA Holds Joint Meeting on Food Safety with Mexican Counterparts Keller and Heckman LLP
Displaying 2325 - 2352 of 12182
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters